MedPath

Observational study on late effects and quality of life (QOL) in long-term survivors after allogeneic hematopoietic stem cell transplantation.

Not Applicable
Conditions
Hematopoietic stem cell trans- plantation targeted diseases such as hematological diseases
Registration Number
JPRN-UMIN000010992
Lead Sponsor
Reserch group for LTF
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patients who were unable to read, understand, or reply to FACT-BMT, SF-36, and the questionnaire about life and social environment. (2)Patients who are disqualified by their attending physician.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath